SCHEMBL28289348

SCHEMBL28289348

CNc1ccc(OCc2ccccc2)c(C(=O)OCc2ccccc2)c1.c1ccc(C2CCCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 1/20 0.47
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
ALDH1A1 P00352 2/20 0.45
LRRK2 Q5S007 2/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PRMT5 O14744 1/20 0.42
CYP19A1 P11511 1/20 0.42
C5AR1 P21730 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CTSV O60911 1/20 0.40
CTSL P07711 1/20 0.40
HTT P42858 1/20 0.40
NPC1 O15118 1/20 0.40
LMNA P02545 1/20 0.40
HRH3 Q9Y5N1 2/20 0.40
NAAA Q02083 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28289353 0.92 SGMS2 (0.44) SGMS2MEN1KMT2AALDH1A1LRRK2
SCHEMBL15534323 0.86 EGFR (0.47) SGMS2MEN1KMT2AALDH1A1LRRK2
SCHEMBL28289352 0.82 RAB9A (0.53) KMT2AALDH1A1CYP3A4TSHRHSD17B10
SCHEMBL10246040 0.78 EGFR (0.45) SGMS2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL28289347 0.77 SGMS2 (0.48) SGMS2MEN1KMT2AALDH1A1LRRK2
SCHEMBL22090555 0.75 ALDH1A1 (0.63) KMT2AALDH1A1CYP3A4TSHRSMN1; SMN2
SCHEMBL20401137 0.75 EGFR (0.43) SGMS2MEN1KMT2AALDH1A1LRRK2
SCHEMBL20400394 0.74 SGMS2 (0.41) SGMS2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL20401050 0.73 CA1 (0.44) SGMS2MEN1KMT2AALDH1A1TSHR
SCHEMBL10246338 0.72 STAT3 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110003104-A Salicyclic acid derivatives, its pharmaceutically acceptable salt, its composition and its application method 多伦多大学管理委员会 2019-07-12 CN disclosed
CN-105120854-B Novel salicylic acid derivatives, pharmaceutically acceptable salts thereof, compositions thereof, and methods of use thereof 多伦多大学管理委员会 2019-04-09 CN disclosed